Nukkleus Inc. (NASDAQ:DFNS – Get Free Report) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totaling 301,468 shares, a growth of 108.6% from the August 15th total of 144,490 shares. Currently, 20.4% of the shares of the stock are short sold. Based on an average daily volume of 1,811,869 shares, the short-interest ratio is currently 0.2 days.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. Wall Street Zen cut shares of Nukkleus from a “sell” rating to a “strong sell” rating in a report on Saturday, September 5th. Weiss Ratings cut Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. Finally, Noble Financial upgraded Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, Nukkleus presently has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on DFNS
Nukkleus Price Performance
Nukkleus (NASDAQ:DFNS – Get Free Report) last announced its earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The business had revenue of $4.00 million for the quarter, compared to analyst estimates of $4.50 million. As a group, analysts predict that Nukkleus will post -3.9 EPS for the current fiscal year.
About Nukkleus
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
See Also
- Five stocks we like better than Nukkleus
- The Ultimate Cyber Shield: CrowdStrike Rises Past $235
- Palantir Just Told Wall Street Where AI Infrastructure Is Headed
- Homebuilders Are Down for the Year, Is Wall Street in Denial?
- Turning Trash to Cash: A $129M Bet on Waste
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
